Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine



   adrenoleukodystrophy
  

Disease ID 264
Disease adrenoleukodystrophy
Definition
An X-linked recessive disorder characterized by the accumulation of saturated very long chain fatty acids in the LYSOSOMES of ADRENAL CORTEX and the white matter of CENTRAL NERVOUS SYSTEM. This disease occurs almost exclusively in the males. Clinical features include the childhood onset of ATAXIA; NEUROBEHAVIORAL MANIFESTATIONS; HYPERPIGMENTATION; ADRENAL INSUFFICIENCY; SEIZURES; MUSCLE SPASTICITY; and DEMENTIA. The slowly progressive adult form is called adrenomyeloneuropathy. The defective gene ABCD1 is located at Xq28, and encodes the adrenoleukodystrophy protein (ATP-BINDING CASSETTE TRANSPORTERS).
Synonym
addison disease and cerebral sclerosis
addison-schilder disease
adrenoleucodystrophy
adrenoleukodystrophy (ald)
adrenoleukodystrophy (disorder)
adrenoleukodystrophy [disease/finding]
adrenoleukodystrophy, x-linked
adrenomyeloneuropathy
ald
ald (adrenoleukodystrophy)
ald - adrenoleukodystrophy
bronze schilder disease
leukodystrophies, melanodermic
leukodystrophy, melanodermic
melanodermic leukodystrophy
schilder addison complex
schilder-addison complex
siemerling creutzfeldt disease
siemerling-creutzfeld disease
siemerling-creutzfeldt disease
x ald
x ald (x linked adrenoleukodystrophy)
x linked adrenoleukodystrophy
x-ald
x-ald (x-linked adrenoleukodystrophy)
x-linked adrenoleucodystrophy
x-linked adrenoleukodystrophy
Orphanet
OMIM
DOID
UMLS
C0162309
MeSH
SNOMED-CT
Comorbidity
UMLS | Disease | Sentences' Count(Total Sentences:16)
C1527231  |  adrenomyeloneuropathy  |  3
C1565489  |  renal insufficiency  |  2
C0001623  |  adrenal insufficiency  |  2
C0037928  |  myelopathy  |  2
C0162309  |  adrenoleukodystrophy  |  1
C0007795  |  schilder's disease  |  1
C0026847  |  spinal muscular atrophy  |  1
C0031039  |  pericardial effusion  |  1
C0162309  |  x-linked adrenoleukodystrophy  |  1
C0035078  |  renal failure  |  1
C0029124  |  optic nerve atrophy  |  1
C0026846  |  muscular atrophy  |  1
C0014130  |  endocrine disorders  |  1
C0001623  |  adrenal failure  |  1
C0011303  |  demyelinating disorders  |  1
C0030442  |  bulbar palsy  |  1
Curated Gene
Entrez_id | Symbol | Resource(Total Genes:6)
3162  |  HMOX1  |  CTD_human
3458  |  IFNG  |  CTD_human
55670  |  PEX26  |  CTD_human
5194  |  PEX13  |  CTD_human
215  |  ABCD1  |  CLINVAR;CTD_human;GHR;ORPHANET;UNIPROT
6648  |  SOD2  |  CTD_human
Inferring Gene
Entrez_id | Symbol | Resource(Total Genes:7)
215  |  ABCD1  |  CIPHER;CTD_human
3123  |  HLA-DRB1  |  CIPHER
3458  |  IFNG  |  CTD_human
55670  |  PEX26  |  CTD_human
3162  |  HMOX1  |  CTD_human
5194  |  PEX13  |  CTD_human
6648  |  SOD2  |  CTD_human
Text Mined Gene
Entrez_id | Symbol | Score | Resource(Total Genes:91)
20  |  ABCA2  |  1.62  |  DISEASES
340273  |  ABCB5  |  1.071  |  DISEASES
5825  |  ABCD3  |  6.291  |  DISEASES
5826  |  ABCD4  |  5.685  |  DISEASES
30  |  ACAA1  |  1.484  |  DISEASES
37  |  ACADVL  |  1.027  |  DISEASES
186  |  AGTR2  |  1.077  |  DISEASES
224  |  ALDH3A2  |  1.077  |  DISEASES
226  |  ALDOA  |  2.963  |  DISEASES
414  |  ARSD  |  1.832  |  DISEASES
10134  |  BCAP31  |  3.717  |  DISEASES
617  |  BCS1L  |  1.557  |  DISEASES
622  |  BDH1  |  2.138  |  DISEASES
912  |  CD1D  |  1.091  |  DISEASES
55835  |  CENPJ  |  1.55  |  DISEASES
10390  |  CEPT1  |  2.586  |  DISEASES
9023  |  CH25H  |  1.901  |  DISEASES
80347  |  COASY  |  1.505  |  DISEASES
5476  |  CTSA  |  1.361  |  DISEASES
1589  |  CYP21A2  |  1.163  |  DISEASES
117154  |  DACH2  |  2.522  |  DISEASES
64834  |  ELOVL1  |  5.527  |  DISEASES
2053  |  EPHX2  |  1.809  |  DISEASES
2108  |  ETFA  |  1.318  |  DISEASES
2109  |  ETFB  |  2.148  |  DISEASES
2195  |  FAT1  |  1.826  |  DISEASES
2224  |  FDPS  |  1.543  |  DISEASES
2556  |  GABRA3  |  1.906  |  DISEASES
8443  |  GNPAT  |  3.071  |  DISEASES
9563  |  H6PD  |  1.262  |  DISEASES
3052  |  HCCS  |  1.123  |  DISEASES
3105  |  HLA-A  |  1.004  |  DISEASES
3123  |  HLA-DRB1  |  1.115  |  DISEASES
3155  |  HMGCL  |  1.575  |  DISEASES
3157  |  HMGCS1  |  1.818  |  DISEASES
3158  |  HMGCS2  |  1.577  |  DISEASES
3295  |  HSD17B4  |  4.638  |  DISEASES
5654  |  HTRA1  |  1.703  |  DISEASES
10581  |  IFITM2  |  1.054  |  DISEASES
3619  |  INCENP  |  1.905  |  DISEASES
9314  |  KLF4  |  1.011  |  DISEASES
55554  |  KLK15  |  1.547  |  DISEASES
3988  |  LIPA  |  1.767  |  DISEASES
4043  |  LRPAP1  |  1.005  |  DISEASES
4099  |  MAG  |  1.231  |  DISEASES
4145  |  MATK  |  1.064  |  DISEASES
4155  |  MBP  |  1.759  |  DISEASES
4158  |  MC2R  |  1.011  |  DISEASES
219541  |  MED19  |  1.55  |  DISEASES
4340  |  MOG  |  1.228  |  DISEASES
4536  |  MT-ND2  |  1.002  |  DISEASES
4878  |  NPPA  |  2.364  |  DISEASES
4879  |  NPPB  |  1.261  |  DISEASES
190  |  NR0B1  |  2.277  |  DISEASES
4306  |  NR3C2  |  2.674  |  DISEASES
2516  |  NR5A1  |  1.45  |  DISEASES
27445  |  PCLO  |  1.064  |  DISEASES
5195  |  PEX14  |  3.536  |  DISEASES
5824  |  PEX19  |  2.123  |  DISEASES
5828  |  PEX2  |  1.671  |  DISEASES
55670  |  PEX26  |  2.391  |  DISEASES
8504  |  PEX3  |  2.083  |  DISEASES
5830  |  PEX5  |  6.227  |  DISEASES
5251  |  PHEX  |  2.45  |  DISEASES
5256  |  PHKA2  |  1.419  |  DISEASES
8605  |  PLA2G4C  |  2.241  |  DISEASES
5365  |  PLXNB3  |  3.344  |  DISEASES
10957  |  PNRC1  |  1.915  |  DISEASES
5725  |  PTBP1  |  1.004  |  DISEASES
58155  |  PTBP2  |  1.567  |  DISEASES
374308  |  PTCHD3  |  1.09  |  DISEASES
23543  |  RBFOX2  |  1.777  |  DISEASES
51128  |  SAR1B  |  1.692  |  DISEASES
54938  |  SARS2  |  1.267  |  DISEASES
6319  |  SCD  |  1.173  |  DISEASES
6342  |  SCP2  |  3.326  |  DISEASES
57515  |  SERINC1  |  2.283  |  DISEASES
26503  |  SLC17A5  |  1.61  |  DISEASES
10165  |  SLC25A13  |  1.736  |  DISEASES
10478  |  SLC25A17  |  6.584  |  DISEASES
788  |  SLC25A20  |  2.17  |  DISEASES
8671  |  SLC4A4  |  1.729  |  DISEASES
9498  |  SLC4A8  |  1.099  |  DISEASES
6646  |  SOAT1  |  2.391  |  DISEASES
25803  |  SPDEF  |  1.165  |  DISEASES
6720  |  SREBF1  |  1.6  |  DISEASES
6721  |  SREBF2  |  1.45  |  DISEASES
26576  |  SRPK3  |  2.888  |  DISEASES
7124  |  TNF  |  1.102  |  DISEASES
89910  |  UBE3B  |  1.29  |  DISEASES
7503  |  XIST  |  2.018  |  DISEASES
Locus(Waiting for update.)
Disease ID 264
Disease adrenoleukodystrophy
Integrated Phenotype(Waiting for update.)
Text Mined Phenotype
HPO | Name | Sentences' Count(Total Phenotypes:13)
Disease ID 264
Disease adrenoleukodystrophy
Manually Symptom
UMLS  | Name(Total Manually Symptoms:7)
C2364324  |  increased intracranial pressure
C1839611  |  n syndrome
C1336970  |  visual manifestations
C0221505  |  cerebral lesions
C0040034  |  thrombocytopenia
C0029124  |  optic nerve atrophy
C0014130  |  endocrine disease
Text Mined Symptom
UMLS | Name | Sentences' Count(Total Symptoms:1)
C0029124  |  optic nerve atrophy  |  1
Manually Genotype(Total Manually Genotypes:1)
Gene Mutation DOI Article Title
ABCD1-doi:10.1038/gim.2015.51Clinical performance of the CytoScan Dx Assay in diagnosing developmental delay/intellectual disability
Text Mining Genotype(Total Genotypes:0)
(Waiting for update.)
All Snps(Total Genotypes:57)
snpId pubmedId geneId geneSymbol diseaseId sourceId sentence score Year geneSymbol_dbSNP CHROMOSOME POS REF ALT
rs11146842NA215ABCD1umls:C0162309CLINVARNA0.61491071NAABCD1X153743056GA
rs1114684217542813215ABCD1umls:C0162309BeFreeIn the case of X-ALD fibroblasts from an ALD patient (R617H), the mutant ALDP was not detected in the cells, but appeared upon incubation with a proteasome inhibitor.0.614910712007ABCD1X153743056GA
rs128624213NA215ABCD1umls:C0162309CLINVARNA0.61491071NAABCD1;BCAP31X153726137GA
rs128624214NA215ABCD1umls:C0162309CLINVARNA0.61491071NAABCD1X153737214CG
rs128624215NA215ABCD1umls:C0162309CLINVARNA0.61491071NAABCD1X153736195CG,T
rs128624216NA215ABCD1umls:C0162309CLINVARNA0.61491071NAABCD1;BCAP31X153725709AG
rs128624217NA215ABCD1umls:C0162309CLINVARNA0.61491071NAABCD1;BCAP31X153725786TG
rs128624218NA215ABCD1umls:C0162309CLINVARNA0.61491071NAABCD1;BCAP31X153726062GA
rs128624219NA215ABCD1umls:C0162309CLINVARNA0.61491071NAABCD1X153736232GA
rs128624220NA215ABCD1umls:C0162309CLINVARNA0.61491071NAABCD1X153736372CT
rs128624221NA215ABCD1umls:C0162309CLINVARNA0.61491071NAABCD1X153736510CT
rs128624222NA215ABCD1umls:C0162309CLINVARNA0.61491071NAABCD1X153737192GA,T
rs1286242237876858215ABCD1umls:C0162309BeFreeA missense point mutation (Ser515Phe) in the adrenoleukodystrophy gene in a family with adrenomyeloneuropathy: a clinical, biochemical, and genetic study.0.614910711995ABCD1X153740147CT
rs1286242237876858215ABCD1umls:C1527231BeFreeA missense point mutation (Ser515Phe) in the adrenoleukodystrophy gene in a family with adrenomyeloneuropathy: a clinical, biochemical, and genetic study.0.1262431631995ABCD1X153740147CT
rs128624223NA215ABCD1umls:C0162309CLINVARNA0.61491071NAABCD1X153740147CT
rs128624224NA215ABCD1umls:C0162309CLINVARNA0.61491071NAABCD1X153740155CT
rs128624225NA215ABCD1umls:C0162309CLINVARNA0.61491071NAABCD1X153743023CT
rs150346282NA215ABCD1umls:C0162309CLINVARNA0.61491071NAABCD1X153743031GA
rs17107315129396556690SPINK1umls:C0162309BeFreeOne ACP patient (2.2%) was found to carry the most common mutation (N34S) of SPINK1 compared to none of the ALD patients (P=NS).0.0002714422003SPINK15147828115TC
rs179986422861370729230CCR2umls:C0162309BeFreeWe also studied the relationship between -2518 A > G CCL2 and CCR2 190 A/G polymorphisms and severity of ALD.0.0002714422012CCR2346357717GA
rs1799945102352733077HFEumls:C0162309BeFreeTo study the role of hemochromatosis gene mutations on the pathogenesis of alcoholic liver disease (ALD), we have analyzed C282Y and H63D mutations on the chromosomes obtained from 95 Japanese alcoholics.0.0010857671999HFE626090951CG
rs1800562102352733077HFEumls:C0162309BeFreeTo study the role of hemochromatosis gene mutations on the pathogenesis of alcoholic liver disease (ALD), we have analyzed C282Y and H63D mutations on the chromosomes obtained from 95 Japanese alcoholics.0.0010857671999HFE626092913GA
rs193922093NA215ABCD1umls:C0162309CLINVARNA0.61491071NAABCD1X153736486-C
rs193922094NA215ABCD1umls:C0162309CLINVARNA0.61491071NAABCD1X153740195TC
rs193922097NA215ABCD1umls:C0162309CLINVARNA0.61491071NAABCD1;BCAP31X153725687GA
rs193922098NA215ABCD1umls:C0162309CLINVARNA0.61491071NAABCD1;BCAP31X153726104CA,T
rs201568579NA215ABCD1umls:C0162309CLINVARNA0.61491071NAABCD1X153740600GA
rs2228603249462821463NCANumls:C0162309BeFreeThe frequency of the NCAN rs2228603 T allele was significantly increased in patients with HCC due to ALD (15.1%) compared to alcoholic cirrhosis without HCC (9.3%), alcoholic controls (7.2%), healthy controls (7.9%), and HCV associated HCC (9.1%).0.0002714422014NCAN1919219115CA,T
rs387906494NA215ABCD1umls:C0162309CLINVARNA0.61491071NAABCD1X153737178AG-
rs387906495NA215ABCD1umls:C0162309CLINVARNA0.61491071NAABCD1X153740155C-
rs387906496NA215ABCD1umls:C0162309CLINVARNA0.61491071NAABCD1;BCAP31X153726137GAG-
rs387906497NA215ABCD1umls:C0162309CLINVARNA0.61491071NAABCD1;BCAP31X153725249GCAGCCAGCCCAGGTGACATGCCGGT-
rs398123100NA215ABCD1umls:C0162309CLINVARNA0.61491071NAABCD1X153737159CT
rs398123102NA215ABCD1umls:C0162309CLINVARNA0.61491071NAABCD1X153740156GA
rs398123103NA215ABCD1umls:C0162309CLINVARNA0.61491071NAABCD1X153740189GA
rs398123104NA215ABCD1umls:C0162309CLINVARNA0.61491071NAABCD1X153740599CA,T
rs398123105NA215ABCD1umls:C0162309CLINVARNA0.61491071NAABCD1X153740618CT
rs398123106NA215ABCD1umls:C0162309CLINVARNA0.61491071NAABCD1X153740710CT
rs398123107NA215ABCD1umls:C0162309CLINVARNA0.61491071NAABCD1X153743008GA
rs398123108NA215ABCD1umls:C0162309CLINVARNA0.61491071NAABCD1X153743211GA
rs398123109NA215ABCD1umls:C0162309CLINVARNA0.61491071NAABCD1;BCAP31X153725297CGGGGGAACACGCTGA-
rs398123110NA215ABCD1umls:C0162309CLINVARNA0.61491071NAABCD1;BCAP31X153725612GA
rs398123111NA215ABCD1umls:C0162309CLINVARNA0.61491071NAABCD1;BCAP31X153725672CT
rs398123112NA215ABCD1umls:C0162309CLINVARNA0.61491071NAABCD1;BCAP31X153725764GGTGGCCCACGCCTACCGCCTCT-
rs398123113NA215ABCD1umls:C0162309CLINVARNA0.61491071NAABCD1;BCAP31X153725880CA,T
rs4010613NA215ABCD1umls:C0162309CLINVARNA0.61491071NAABCD1X153743055CT
rs713993050NA215ABCD1umls:C0162309CLINVARNA0.61491071NAABCD1;BCAP31X153725519-C
rs727503786NA215ABCD1umls:C0162309CLINVARNA0.61491071NAABCD1X153736231CA,G
rs7384092506029280339PNPLA3umls:C0162309BeFreeWe performed a systematic review of previous studies on the relationship between rs738409 of PNPLA3 and ALD and meta-analysis was conducted in a random-effects model.0.0010857672014PNPLA32243928847CG
rs7384092286915780339PNPLA3umls:C0162309BeFreeThe single nucleotide polymorphism (SNP) rs738409 in patatin-like phospholipase domain-containing protein 3 (PNPLA3) is associated with hepatic fat accumulation and disease progression in patients with non-alcoholic fatty liver disease and alcoholic liver disease (ALD).0.0010857672013PNPLA32243928847CG
rs797044610NA215ABCD1umls:C0162309CLINVARNA0.61491071NAABCD1;BCAP31X153726153AG
rs797044611NA215ABCD1umls:C0162309CLINVARNA0.61491071NAABCD1;BCAP31X153726152TC
rs797044625NA215ABCD1umls:C0162309CLINVARNA0.61491071NAABCD1X153743503AC-
rs797044626NA215ABCD1umls:C0162309CLINVARNA0.61491071NAABCD1X153743487AG
rs797044726NA215ABCD1umls:C0162309CLINVARNA0.61491071NAABCD1X153736408CT
rs797044781NA215ABCD1umls:C0162309CLINVARNA0.61491071NAABCD1X153742986GA
rs97374222253809912CD1Dumls:C1527231BeFreeThe minor allele of rs973742 located 4-kb downstream from CD1D was significantly more frequent in AMN patients (χ² = 7.6; P = 0.006).0.0002714422012NA1158190738GA
GWASdb Annotation(Total Genotypes:0)
(Waiting for update.)
GWASdb Snp Trait(Total Genotypes:0)
(Waiting for update.)
Mapped by lexical matching(Total Items:0)
(Waiting for update.)
Mapped by homologous gene(Total Items:0)
(Waiting for update.)
Disease ID 264
Disease adrenoleukodystrophy
Case(Waiting for update.)